Penam Laboratories Limited Unlisted Shares - Company Overview

Penam Laboratories Limited, is an unlisted public company incorporated on 07 August, 1989. It is classified as a public limited company and is located in New Delhi, Delhi. It's authorized share capital is INR 11.00 cr and the total paid-up capital is INR 5.17 cr.

 Penam Laboratories Limited was founded in the year 1989, from a humble beginning. Penam is one of India's renowned producers of Beta Lactam group of Antibiotic Bulk Drugs (APIs) and Formulations.

Penam Laboratories Limited Share Price, Share Details as of March 31, 2025

 Penam Laboratories Limited Incorporation Details

 Penam Laboratories Limited Board of Directors

 Penam Laboratories Ltd Principal Business Activities

Penam Laboratories limited Shareholding Pattern (as on 31-03-2025)

Q: What is the face value of Penam Laboratories Ltd shares?
Answer: The face value of Penam Laboratories Ltd is ₹10 per equity share.

Q: What is the minimum lot size for buying Penam Laboratories shares through WWIPL?
Answer: The minimum lot size for Penam Laboratories shares is 100 equity shares.

Q: How can I buy Penam Laboratories unlisted shares through WWIPL?
Answer: Investors can complete KYC, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.

Q: Why should I buy Penam Laboratories shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in Penam Laboratories Ltd a good idea?
Answer: Investors often evaluate Penam Laboratories based on its pharmaceutical manufacturing capabilities, product portfolio, regulatory compliance, and long-term growth prospects.

Q: Why do investors buy Penam Laboratories shares before a potential IPO?
Answer: Investors seek early exposure to a pharmaceutical company before a potential listing, aiming to participate in future value creation and liquidity opportunities.

Q: What business does Penam Laboratories Ltd operate in?
Answer: Penam Laboratories is engaged in the manufacturing and marketing of pharmaceutical formulations, serving domestic and international healthcare markets.

Q: What makes Penam Laboratories different from other unlisted pharmaceutical companies?
Answer: The company focuses on quality pharmaceutical manufacturing, regulatory compliance, and expanding its portfolio across therapeutic segments.

Q: What are the key growth drivers for Penam Laboratories Ltd?
Answer: Rising healthcare expenditure, increasing demand for generic medicines, export opportunities, product launches, and capacity expansion are key growth drivers.

Q: What factors affect the valuation of Penam Laboratories shares?
Answer: Revenue growth, regulatory approvals, product mix, operating margins, profitability, export performance, and R&D investments are key valuation drivers.

Q: Are Penam Laboratories shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my Penam Laboratories shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and availability.

Q: What documents are required to buy Penam Laboratories shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in Penam Laboratories shares?
Answer: Investors should consider regulatory risks, pricing pressure, compliance requirements, competition, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track Penam Laboratories investments?
Answer: WWIPL provides company updates, transaction assistance, market insights, and investment support to help investors stay informed.

Q: How long does it take for Penam Laboratories shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in Penam Laboratories Ltd?
Answer: Investors should assess the company's financial performance, manufacturing capabilities, regulatory track record, product pipeline, profitability, and valuation.

Q: Can Penam Laboratories benefit from the growth of India's pharmaceutical industry?
Answer: Yes. Rising demand for affordable medicines, expanding exports, and increasing healthcare spending may create long-term growth opportunities for the company.